Addison Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Addison Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.5K	Hold	188	–	–	0.01%	390
2026 Q1	$10.2K	Hold	188	–	–	﹤0.01%	659
2025 Q4	$10.5K	Hold	188	–	–	﹤0.01%	621
2025 Q3	$9.01K	Hold	188	–	–	﹤0.01%	645
2025 Q2	$7.63K	Hold	188	–	–	﹤0.01%	654
2025 Q1	$8.23K	Hold	188	–	–	﹤0.01%	608
2024 Q4	$8.08K	Hold	188	–	–	﹤0.01%	615
2024 Q3	$8.34K	Hold	188	–	–	﹤0.01%	612
2024 Q2	$7.48K	Hold	188	–	–	﹤0.01%	597
2024 Q1	$8.11K	Hold	188	–	–	﹤0.01%	536
2023 Q4	$7.83K	Hold	188	–	–	﹤0.01%	537
2023 Q3	$7.47K	Hold	188	–	–	﹤0.01%	509
2023 Q2	$7.71K	Hold	188	–	–	﹤0.01%	499
2023 Q1	$7.71K	Hold	188	–	–	﹤0.01%	486
2022 Q4	$7.7K	Hold	188	–	–	﹤0.01%	465
2022 Q3	$8K	Hold	188	–	–	0.01%	463
2022 Q2	$8K	Hold	188	–	–	﹤0.01%	463
2022 Q1	$9K	Hold	188	–	–	﹤0.01%	494
2021 Q4	$9K	Hold	188	–	–	0.01%	422
2021 Q3	$9K	Hold	188	–	–	0.01%	315
2021 Q2	$10K	Buy	+188	New	+$9.44K	0.01%	304
2020 Q4	$10K	Buy	+188	New	+$8.99K	0.01%	292

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Addison Advisors's XPH Position: Q2 2026 in Review

Addison Advisors held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 188 shares worth $12.5K. The position accounts for 0.01% of the portfolio, ranked #390.

Addison Advisors first reported a position in XPH in Q4 2020 and has held it in 22 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Addison Advisors held 188 shares of State Street SPDR S&P Pharmaceuticals ETF worth $12.5K as of Q2 2026.
Addison Advisors left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Addison Advisors's portfolio in Q2 2026, its #390 holding.
Addison Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2020 and has held it in 22 quarters since.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.